REQUEST A DEMO
Total
USD $0.00
Search more companies

Vergo Pharma Research Private Limited (India)

Main Activities: Research and Development in the Physical, Engineering, and Life Sciences
Full name: Vergo Pharma Research Private Limited Profile Updated: September 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Vergo Pharma Research Private Limited is an unlisted company, incorporated on 23/09/2010. It has its registered office in the State of Goa, India. Company's corporate identification number (CIN) is U73100GA2010PTC014001 and registration number is 014001. The company is a professional, scientific and technical company, it is engaged in scientific research and development.

Legal Address
24/1, D-1, Corlim Industrial Estate, Corlim,
North Goa; Goa; Postal Code: 403110

Contact Details: Purchase the Vergo Pharma Research Private Limited report to view the information.

Website: http://www.vergoclinicals.com

Basic Information
Outstanding Shares:
Purchase the Vergo Pharma Research Private Limited report to view the information.
Registered Capital:
Purchase the Vergo Pharma Research Private Limited report to view the information.
Incorporation Date:
September 23, 2010
Key Executives
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Promoter Director
Purchase this report to view the information.
Managing Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Vergo Pharma Research Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
58.61%
Total operating revenue
59.11%
Operating profit (EBIT)
580.68%
EBITDA
494.48%
Net Profit (Loss) for the Period
580.68%
Total assets
43.67%
Total equity
44.6%
Operating Profit Margin (ROS)
16.73%
Net Profit Margin
16.73%
Return on Equity (ROE)
-73.94%
Debt to Equity Ratio
-115.89%
Quick Ratio
-0.41%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?